FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056634 [Registered on: 18/08/2023] Trial Registered Prospectively
Last Modified On: 16/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A Study On Milaghu Legiyam And Kunthiriga Thailam In The Management Of Vathasthambam 
Scientific Title of Study   An Open Non Randomized Clinical Trial to evaluate the therapeutic effectiveness of Milaghu Legiyam (Internal) And Kunthiriga Thailam (External) in the management of Vathasthambam (Sciatica) in patients reporting at Ayothidoss Pandithar Hospital-OPD, National Institute of Siddha. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S Dharshini 
Designation  PG Scholar 
Affiliation  National Institute of Siddha 
Address  Room No:7/8 Department of Maruthuvam National Institute of Siddha Tambaram Sanatorium Kancheepuram Chennai

Kancheepuram
TAMIL NADU
600047
India 
Phone  6374290636  
Fax  22381314  
Email  dharshiniselvarasu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr H Vetha Merlin Kumari 
Designation  Associate Professor 
Affiliation  National Institute of Siddha 
Address  Room No:7/8 Department of Maruthuvam National Institute of Siddha Tambaram Sanatorium Kancheepuram Chennai

Kancheepuram
TAMIL NADU
600047
India 
Phone  9894782366  
Fax  22381314  
Email  dr.vetha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S Dharshini 
Designation  PG Scholar 
Affiliation  National Institute of Siddha 
Address  Room No:7/8 Department of Maruthuvam National Institute of Siddha Tambaram Sanatorium Kancheepuram Chennai

Kancheepuram
TAMIL NADU
600047
India 
Phone  6374290636  
Fax  22381314  
Email  dharshiniselvarasu@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Siddha Tambaram Sanatorium Chennai 47 
 
Primary Sponsor  
Name  National Institute of Siddha 
Address  Room No 7/8 Department of Maruthuvam National Institute of Siddha Tambaram Sanatorium Kancheepuram Chennai 600047 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S Dharshini  National Institute of Siddha  Room No 7/8 Department of Maruthuvam National Institute of Siddha Tambaram Santorium kancheepuram Chennai 600047
Kancheepuram
TAMIL NADU 
6374290636
22381314
dharshiniselvarasu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National Institute of Siddha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M543||Sciatica,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Milaghu Legiyam(Internal) and Kunthiriga thailam (External)   Milaghu Legiyam (Internal) 6gms Bd with Milk for 48 days Kunthiriga thailam (External) external application for 48 days 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Low back pain radiating to lower limb posterolaterally
Numbness and paresthesia in same distribution
Low back ache aggrevates after prolonged standing and walking
Difficulty in bending and lifting
Coughing exacerbates the low back pain etc
(Any 2 or more symptoms will be included)
2.Positive SLR Test
3.Positive Lasegue Test
4.The Modified Oswestry Disability Scale a score of 40% or more will be taken
5.Patient willing to undergo radiological investigation and laboratory investigation
6.Patient willing to sign the informed consent form 
 
ExclusionCriteria 
Details  1.Uncontrolled Diabetes Mellitus
2.Ankylosis Spondylosis
3.Vertebral fracture and Spinal deformity
4.Cardiac and renal diseases
5.Pregnant and Lactating mother
6.with severe and terminal illness like CA or HIV
7.Not willing to give blood samples for investigation 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Improvement in the Modified Oswestry Low Back Disability Status of the patient before & after the treatment will be obtained
2.Reduction in pain is assesed by using the universal Pain Assesment Scale 
18 MONTHS 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   26/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

INTRODUCTION:

This is an open clinical trial that evaluates therapeutic effectiveness of siddha formulation MILAGHU LEGHIYAM AND KUNTHIRIGA THAILAM in the management of VATHASTHAMBAM (SCIATICA) patients through improvement in The Modified Oswestry Low Back Disability Questionnaire and reduction of pain using the Universal Pain Assesment Scale before and after treatment. Sciatica is a condition characterized by pain affecting the low back, hip and outer side of the leg, caused by compression of a spinal nerve root in the lower back, often owing to degeneration of an inter - vertebral disc. 5%-10% of patients with low back pain have sciatica, whereas the reported lifetime prevalence of low back pain ranges from 49% to 70%. The annual prevalence of disc related sciatica in the general population is estimated at 2.2%.

OBJECTIVE:

PRIMARY OBJECTIVE:

• To assess the therapeutic effectiveness of MILAGHU LEGHIYAM (INTERNAL) and KUNTHIRIKA THAILAM (EXTERNAL) in the management of VATHASTHAMABAM through The Modified Oswestry Low Back Disability Questionnaire and Universal Pain Assessment Scale before and after treatment.

 â€¢ To evaluate the standardization of the trial drug Milaghu leghiyam and Kunthiriga thailam 

SECONDARY OBJECTIVE:

• To evaluate the laboratory parameters before and after the study.

MATERIALS AND METHODS:

A Total of 30 diagnosed  patients of Vathasthambam (Sciatica) within the age limit of 20-60 years willing to participate in the study, by signing the consent form will be enrolled in the study. Uncontrolled Diabetes Mellitus, K/H/O Ankylosing spondylitis, K/H/O Vertebral fracture and Spinal deformity, Cardiac diseases and Renal diseases, Pregnant and lactating women and With severe or terminal illness like CA or HIV, Not willing to sign the informed consent will be excluded. Assessment is done through improvement in The Modified Oswestry Low Back Disability Questionnaire and reduction of pain using the Universal Pain Assesment Scale before and after treatment.

RESULTS AND DISCUSSION:

      The result will be statistically analyzed

KEYWORDS :

Vathasthambam, Sciatica, Milaghu Legiyam 
Close